Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Indianapolis, United StatesPharmaceuticals & BiotechEnterprise

Visit Eli Lilly

Partnerships

Clients

Team+3 more

Jon Wilkerson

jonw@bdainc.com

Executive VP NBD & Client Services

Brenda Harrington

bharrington@butler.edu

Human Resources professional

Team

Founded

1876

Employees

47,000

Featured companies:

Similar to Eli Lilly

View all companies

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Tokyo, JapanPharmaceuticals & Biotech

Bristol Myers Squibb

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Princeton, United StatesPharmaceuticals & Biotech